Migration and Invasion in Brain Neoplasms

Overview

Journal Curr Neurol Neurosci Rep

Specialty Neurology

Date 2002 Mar 20

PMID 11898522

Citations 27

Authors

A J Bolteus

M E Berens

G J Pilkington

Affiliations

Soon will be listed here.

Abstract

Local invasion of the brain by neoplastic glial cells is a major obstacle to effective treatment of intrinsic brain tumors. Invasion is directly related to histologic malignancy, but occurs to some extent irrespective of tumor grade. Because the brain-to-tumor interface is not well demarcated, total surgical removal is rarely possible; moreover, as invading cells transiently arrest from cell division they are refractory to radiotherapeutic intervention. Invading cells may also be protected from the action of cytotoxic drugs by the presence of an intact blood-brain barrier. The invading cells, having migrated several millimeters or even centimeters from the main focus of the tumor, return to cycle phase under the control of some as yet unknown microenvironmental cue to form a recurrent tumor adjacent to the original site of presentation. Recent cellular and genetic information concerning factors underlying invasion may not only yield suitable targets for adaptation of existing therapies, but may also lead to novel approaches in glioma management.

Citing Articles

Role of UBE2C in Brain Cancer Invasion and Dissemination.

Domentean S, Paisana E, Cascao R, Faria C Int J Mol Sci. 2023; 24(21).

PMID: 37958776 PMC: 10650073. DOI: 10.3390/ijms242115792.

Screening MT1-MMP Activity and Inhibition in Three-Dimensional Tumor Spheroids.

Knapinska A, Drotleff G, Chai C, Twohill D, Ernce A, Tokmina-Roszyk D Biomedicines. 2023; 11(2).

PMID: 36831098 PMC: 9953393. DOI: 10.3390/biomedicines11020562.

N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).

Zhang X, Chen Q, Li Y, Chen H, Jiang Q, Hu Q Biomed Res Int. 2022; 2022:3233004.

PMID: 35813230 PMC: 9262576. DOI: 10.1155/2022/3233004.

The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy.

Behnam M, Motamedzadeh A, Aalinezhad M, Dadgostar E, Rashidi Noshabad F, Pourfridoni M Mol Biol Rep. 2022; 49(11):10609-10615.

PMID: 35715607 DOI: 10.1007/s11033-022-07656-y.

A Tumor Suppressor Gene, N-myc Downstream-Regulated Gene 1 (NDRG1), in Gliomas and Glioblastomas.

Nakahara Y, Ito H, Namikawa H, Furukawa T, Yoshioka F, Ogata A Brain Sci. 2022; 12(4).

PMID: 35448004 PMC: 9029626. DOI: 10.3390/brainsci12040473.

References

Miyake K, Kimura S, Nakanishi M, Hisada A, Hasegawa M, Nagao S . Transforming growth factor-beta1 stimulates contraction of human glioblastoma cell-mediated collagen lattice through enhanced alpha2 integrin expression. J Neuropathol Exp Neurol. 2000; 59(1):18-28. DOI: 10.1093/jnen/59.1.18. View

Kitange G, Shibata S, Tokunaga Y, Yagi N, Yasunaga A, Kishikawa M . Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. Lab Invest. 1999; 79(4):407-16. View

Pilkington C . The role of the extracellular matrix in neoplastic glial invasion of the nervous system. Braz J Med Biol Res. 1996; 29(9):1159-72. View

Velasco G, Cal S, Ferrando A, Alvarez S, Nakano A, Arribas J . Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res. 2000; 60(4):877-82. View

Maidment S, Rucklidge G, Rooprai H, Pilkington G . An inverse correlation between expression of NCAM-A and the matrix-metalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro. Cancer Lett. 1997; 116(1):71-7. DOI: 10.1016/s0304-3835(97)00171-7. View

Moriyama T, Kataoka H, Koono M, Wakisaka S . Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review). Int J Mol Med. 1999; 3(5):531-6. DOI: 10.3892/ijmm.3.5.531. View

Forsyth P, Wong H, Laing T, Rewcastle N, Morris D, Muzik H . Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer. 1999; 79(11-12):1828-35. PMC: 2362801. DOI: 10.1038/sj.bjc.6690291. View

Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H . Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol. 1999; 154(2):417-28. PMC: 1850004. DOI: 10.1016/S0002-9440(10)65288-1. View

Okada H, Yoshida J, Sokabe M, Wakabayashi T, Hagiwara M . Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int J Cancer. 1996; 66(2):255-60. DOI: 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A. View

10.

Merzak A, Koocheckpour S, Pilkington G . CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res. 1994; 54(15):3988-92. View

11.

Qin H, Sun Y, Benveniste E . The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem. 1999; 274(41):29130-7. DOI: 10.1074/jbc.274.41.29130. View

12.

Koochekpour S, Merzak A, Pilkington G . Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett. 1996; 102(1-2):209-15. DOI: 10.1016/0304-3835(96)04161-4. View

13.

Tonn J, Kerkau S, Hanke A, Bouterfa H, Mueller J, Wagner S . Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer. 1999; 80(5):764-72. DOI: 10.1002/(sici)1097-0215(19990301)80:5<764::aid-ijc22>3.0.co;2-j. View

14.

Lamszus K, Laterra J, Westphal M, Rosen E . Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci. 1999; 17(5-6):517-30. DOI: 10.1016/s0736-5748(99)00008-8. View

15.

Novak U, Stylli S, Kaye A, Lepperdinger G . Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res. 2000; 59(24):6246-50. View

16.

Welch W, KORNBLITH P, Michalopoulos G, Petersen B, Beedle A, Gollin S . Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells. Anticancer Res. 1999; 19(3A):1635-40. View

17.

Steck P, Pershouse M, Jasser S, Yung W, Lin H, Ligon A . Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997; 15(4):356-62. DOI: 10.1038/ng0497-356. View

18.

Kitange G, Kishikawa M, Nakayama T, Naito S, Iseki M, Shibata S . Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. Mod Pathol. 1999; 12(6):618-26. View

19.

Bouterfa H, Darlapp A, Klein E, Pietsch T, Roosen K, Tonn J . Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions. J Neurooncol. 1999; 44(1):23-33. DOI: 10.1023/a:1006331416283. View

20.

Mueller M, Riede D, Lange M, Steiner H, Fusenig N . Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol. 1999; 155(5):1557-67. PMC: 1866994. DOI: 10.1016/S0002-9440(10)65472-7. View